CN109481497A - 一种缓解口腔及咽喉不适的含片及其制备方法 - Google Patents
一种缓解口腔及咽喉不适的含片及其制备方法 Download PDFInfo
- Publication number
- CN109481497A CN109481497A CN201811568246.3A CN201811568246A CN109481497A CN 109481497 A CN109481497 A CN 109481497A CN 201811568246 A CN201811568246 A CN 201811568246A CN 109481497 A CN109481497 A CN 109481497A
- Authority
- CN
- China
- Prior art keywords
- parts
- lozenge
- spare
- peppermint
- throat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007937 lozenge Substances 0.000 title claims abstract description 33
- 210000000214 mouth Anatomy 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 45
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 45
- 229920002472 Starch Polymers 0.000 claims abstract description 39
- 239000008107 starch Substances 0.000 claims abstract description 39
- 235000019698 starch Nutrition 0.000 claims abstract description 39
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 37
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 37
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 37
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 37
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 30
- 239000003507 refrigerant Substances 0.000 claims abstract description 29
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 17
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 17
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 17
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 239000011734 sodium Substances 0.000 claims abstract description 16
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 16
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 15
- 239000000654 additive Substances 0.000 claims abstract description 11
- 230000000996 additive effect Effects 0.000 claims abstract description 11
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 7
- 239000003765 sweetening agent Substances 0.000 claims abstract description 7
- 244000269722 Thea sinensis Species 0.000 claims abstract 6
- 239000000843 powder Substances 0.000 claims description 37
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 32
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 29
- 229930006000 Sucrose Natural products 0.000 claims description 29
- 229960004793 sucrose Drugs 0.000 claims description 29
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 24
- 229940041616 menthol Drugs 0.000 claims description 24
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000004376 Sucralose Substances 0.000 claims description 20
- 235000019408 sucralose Nutrition 0.000 claims description 20
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 20
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 18
- 229930195725 Mannitol Natural products 0.000 claims description 18
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 18
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 18
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 18
- 239000000594 mannitol Substances 0.000 claims description 18
- 235000010355 mannitol Nutrition 0.000 claims description 18
- 239000008868 Flower Essence Substances 0.000 claims description 17
- 241000207840 Jasminum Species 0.000 claims description 17
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 17
- 239000011812 mixed powder Substances 0.000 claims description 17
- 239000001569 carbon dioxide Substances 0.000 claims description 16
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 16
- 239000002245 particle Substances 0.000 claims description 15
- 239000008187 granular material Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 13
- 235000019477 peppermint oil Nutrition 0.000 claims description 13
- 239000003826 tablet Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 9
- 206010013786 Dry skin Diseases 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 239000002002 slurry Substances 0.000 claims description 7
- 239000011122 softwood Substances 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 235000015424 sodium Nutrition 0.000 claims description 5
- 235000019605 sweet taste sensations Nutrition 0.000 claims description 5
- -1 mixing Uniformly Substances 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 239000000796 flavoring agent Substances 0.000 abstract description 13
- 235000019634 flavors Nutrition 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 230000007774 longterm Effects 0.000 abstract description 5
- 238000012216 screening Methods 0.000 abstract description 5
- 208000017667 Chronic Disease Diseases 0.000 abstract description 3
- 235000019640 taste Nutrition 0.000 abstract description 3
- 230000009747 swallowing Effects 0.000 abstract 1
- 241001122767 Theaceae Species 0.000 description 39
- 229940032147 starch Drugs 0.000 description 30
- 210000003800 pharynx Anatomy 0.000 description 26
- 239000000047 product Substances 0.000 description 18
- 239000003814 drug Substances 0.000 description 10
- 229920002774 Maltodextrin Polymers 0.000 description 9
- 239000005913 Maltodextrin Substances 0.000 description 9
- 229940035034 maltodextrin Drugs 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 201000007100 Pharyngitis Diseases 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 240000002853 Nelumbo nucifera Species 0.000 description 4
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 4
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 4
- 208000020670 canker sore Diseases 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 210000000697 sensory organ Anatomy 0.000 description 4
- 235000019614 sour taste Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000003705 Senecio vulgaris Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241001534869 Terminalia Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Insects & Arthropods (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种缓解口腔及咽喉不适的含片及其制备方法,由下述重量份的原料制成:百药煎10‑20份,薄荷5‑20份,微晶纤维素10‑40份,甜味剂30‑95份,羧甲基淀粉钠2‑8份,淀粉0.5‑1.5份,清凉添加剂0.2‑0.6,硬脂酸镁0.1‑1.0份。本发明以具有清咽润喉功效的百叶煎和薄荷为原料,二者配伍使用,并通过添加剂的筛选,克服了百药煎酸涩难咽的缺点,制备得到的含片口感清凉冰爽,风味独特,具有较好的缓解口腔及咽喉不适的功效,是一种清咽利喉,功效与口感兼具的产品,能实现长期服用以舒缓口腔、咽喉等慢性病症的目的。
Description
技术领域
本发明涉及片剂领域,具体涉及一种缓解口腔及咽喉不适的含片及其制备方法。
背景技术
含片是指含于口腔中缓慢溶化,产生局部或全身作用的片剂。含片中的原料药物一般是易溶性的,主要起局部消炎、杀菌、收敛、止痛或局部麻醉等作用。
随着社会经济的快速发展,生活节奏的加快,心理压力的增大,自然环境的污染等,导致人们普遍性的出现口腔溃疡,咽喉不适等“现代文明病”。而百药煎主要用于肺热咳嗽,风火牙痛,口舌糜烂等症,非常适合用于改善口腔溃疡,咽喉不适等症。目前市面上已有一些含百药煎的清热利咽的产品,如:专利200810247013.3公开了一种由川贝母、诃子肉、百药煎等药材经打粉或提取,再压片所制得的,具有清热利咽功效的片剂;专利201610164749.9公开了一种由百药煎、夏枯草、女贞子等药材所制得的,具有明目润喉功效的保健茶;专利201510517278.0公开了由草河车、斩龙草、百药煎等药材所制得的,具有清热解毒,活血止痛等功效,对慢性咽炎有较好疗效的饮料。
然而现有的百药煎清咽利喉功效产品,酸涩难咽,口感较差,消费者体验感差;纵使产品具有一定的疗效,但难以实现口腔溃疡、慢性咽炎等需长期服药调理的患者对产品口感的需求。
发明内容
为了克服上述现有技术的不足,本发明的首要目的在于提供一种缓解口腔及咽喉不适的含片,该含片酸甜可口,清凉冰爽,风味独特,具有较好的缓解口腔及咽喉不适的功效。
本发明的另一目的在于提供上述缓解口腔及咽喉不适的含片的制备方法。
本发明是通过以下技术方案实现;
一种缓解口腔及咽喉不适的含片,由下述重量份的原料制成:百药煎10-20份,薄荷5-20份,微晶纤维素10-40份,甜味剂30-95份,羧甲基淀粉钠2-8份,淀粉0.5-1.5份,清凉添加剂0.2-0.6,硬脂酸镁0.1-1.0份。
作为本发明进一步优选的技术方案,所述一种缓解口腔及咽喉不适的含片,由下述重量份的原料制成:百药煎12.5份,薄荷10份,微晶纤维素20.5份,甜味剂63份,羧甲基淀粉钠4份,淀粉0.8份,清凉添加剂0.25份,硬脂酸镁0.5份,薄荷脑0.1份。
本发明中各原料的药理作用如下报述:
百药煎:性平,味酸、甘;归肺、胃经。清热化痰,生津止渴。用于肺热咳嗽,风火牙痛,口舌糜烂,风湿诸疮等症。百药煎由五倍子、茶叶经过发酵而得,产品中含有丰富的没食子酸,没食子酸具有抗炎、抗突变、抗氧化、抗自由基等多种生物学活性,同时具有抗菌抗病毒作用,体外对金黄色葡萄球菌、绿脓杆菌、弗氏痢疾杆菌等有抑制作用,对流感病毒亦有一定抑制作用。
薄荷:性凉,味辛;归肺、肝经。疏散风热,清利头目,利咽,透疹,疏肝行气。可用于风热头痛,目赤,喉痹,口疮,胸胁胀闷等症。薄荷含有挥发性油、蛋白质、脂肪、碳水化合物、矿物质、维生素等成分。薄荷挥发油中的薄荷脑成分具有杀菌止痒功效,涂于局部可刺激神经而引起凉感,并抑制痛觉神经,还可舒缓呼吸道,具有清咽止咳功能。
本发明用百药煎和薄荷配伍使用,再配以其他辅料,可以明显改善产品的酸涩味,制备得到的含片酸甜可口,清凉冰爽,风味独特,可以快速缓解因口腔溃疡、咳嗽痰多或咽喉肿痛引起的不适。
本发明还公开了上述的一种缓解口腔及咽喉不适的含片的制备方法,包括如下步骤:
a)取薄荷,洗净,50℃以下低温干燥,粉碎成40-60目粉末,用超临界二氧化碳萃取,得薄荷油,备用;取百药煎,除去杂质,备用;
b)取超临界二氧化碳萃取后的薄荷,加入百药煎,加水提取两次,第一次加7-8倍量水,煎煮20-30分钟,第二次加6-7倍量水,煎煮20-30分钟,滤过,合并滤液,在60-80℃下减压浓缩到相对密度为1.06-1.10的清膏,采用喷雾干燥制备得到混合提取物,备用;
c)取薄荷脑,粉碎后过80-100目筛,备用;
d)取三氯蔗糖、蔗糖粉、微晶纤维素、甘露糖醇、羧甲基淀粉钠及b)中混合提取物,混合均匀,得到混合粉,备用;
e)取淀粉,加水制成淀粉浆,均匀倒入d)中的混合粉中,充分混匀,制成软材,后用摇摆制粒机制备得到颗粒,备用;
f)取步骤e)得到颗粒,加入硬脂酸镁,薄荷香精、茉莉花香精,以及c)中的薄荷脑,混合均匀,再均匀喷入a)中的薄荷油,得到颗粒混合物,备用;
g)取f)中的颗粒混合物,用压片机制备得到含片,即得。
本发明通过实验进一步优选了超临界二氧化碳萃取薄荷的工艺,所述超临界二氧化碳萃取的条件为:萃取釜压力20~25MPa,分离Ⅰ压力5~10MPa,分离Ⅱ压力4~8MPa,萃取温度为35~45℃,分离Ⅰ温度为45~55℃,分离Ⅱ温度为30~35℃,二氧化碳流量为20-30L/h,萃取时间为1.5-3小时。
为了更好地实现本发明的技术效果,本发明分别对糖药比、载药量、清凉度进行了优化研究,具体过程如下:
试验1:糖药比的筛选:
实验方法:
因百药煎原料味酸涩难咽,需加入适当调味剂改善口感,按下表百药煎与蔗糖粉进行配比,分别对口感进行感官分析(满分10分),确定较佳的糖药比(蔗糖粉:百药煎),具体结果如下表:
由实验数据可得,蔗糖粉与百药煎质量比在10.5-16.5时,产品酸甜适中,感官评分较高,尤其是当糖药比为13.5时,评分达到9.20,因此确定糖药比在10.5-16.5为优选范围。
试验2:载药量的筛选
实验方法:
在试验1糖药比的基础上,通过添加适量的甜味剂来替代蔗糖粉,以提高含片中百药煎的含量,提升产品的药效,其中三氯蔗糖甜度相当于600倍蔗糖甜度,甘露糖醇甜度相当于0.5倍蔗糖甜度,甘露糖醇虽然甜度较低,但是其具有较好的风味及口感,因此也作为备选原料进行筛选。
按下表分别取百药煎,破碎全部通过10目,加15倍水煎煮提取30分钟,提取液经浓缩后进行喷雾干燥,再按下表加入蔗糖粉、三氯蔗糖、甘露糖醇,得混合粉。分别取相同比例百药煎药材量的混合粉进行感官分析(满分10分),确定较佳的载药量(百药煎/混合粉),具体结果如下表:
由实验数据可得,蔗糖粉与百药煎质量比在13.5:1时,若全部选用蔗糖粉,载药量只有0.07,但是,通过甜度换算,使用部分甜味剂可以有效提高载药量,如试验序号3,所有蔗糖粉都用三氯蔗糖替代,载药量高达44.64,不过所得产品口感单薄,感官评分较低,因此在提高载药量的同时,也需提升产品的风味和口感。试验发现,蔗糖粉、三氯蔗糖及甘露糖醇的复配使用,能使载药量得到一定的提升,同时口感饱满,酸甜可口,带有清凉感,感官评分较高,尤其是7号,评分达到9.31,因此确定,蔗糖粉、三氯蔗糖和甘露糖醇按25-45:9.8-48:0.19-0.22复配使用,优选蔗糖粉35份,三氯蔗糖0.2份,甘露糖醇27.6份。
试验3:清凉感的筛选:
实验方法:
清凉感能清新口气,舒缓咽喉不适,增强产品的药效作用。清凉感的产生主要是薄荷醇等物质刺激了皮肤上冷受体,经过神经传递到大脑,让大脑产生“温度低了”的错觉,因此,在处方中适当添加清凉感添加剂,可以提升产品清凉感。按下表比例进行配比,适当粉碎后再加麦芽糊精调整至100份,分别对清凉感进行感官分析(满分10分),确定较优的清凉感添加剂的比例,具体结果如下表:
由实验数据可得,冰片的感官评分较低,主要是冰片有清凉感,但单薄,不如薄荷脑的感官丰富,薄荷脑能提供丰富的咽喉清凉感,而薄荷香精和茉莉花香精则能很好的从气味上提供清香、清凉感,因此选择薄荷脑、薄荷香精及茉莉花香精复配作为清凉添加剂。从实验数据可以发现,薄荷香精0.1-0.3份,茉莉花香精0.05-0.15,薄荷脑0.05-0.15份时,产品具有较好的清凉感效果,更优选为薄荷香精0.2份,茉莉花香精0.05,薄荷脑0.1份。
与现有技术相比,本发明具有如下有益效果:
(1)本发明以具有清咽润喉功效的百叶煎和薄荷为原料,二者配伍使用,并通过添加剂的筛选,以蔗糖粉、三氯蔗糖、甘露糖醇复配使用,可以提高片剂载药量,保证产品疗效,同时尽可能改善口感,提高产品长期服用依从性;薄荷脑复配薄荷香精、茉莉花香精成清凉添加剂,不仅保持产品清凉感,同时提供清香口感,进一步改善了百药煎的酸涩味,制备得到的含片口感清凉冰爽,风味独特,具有较好的缓解口腔及咽喉不适的功效,是一种清咽利喉,功效与口感兼具的产品,能实现长期服用以舒缓口腔、咽喉等慢性病症的目的。
(2)本发明的制备工艺通过优化,薄荷原料预先采用超临界萃取方法提取挥发油,薄荷油均匀喷洒于颗粒表面,最大限度地保留了薄荷的特殊香气,并增强了清凉感。
具体实施方式
下面通过具体实施方式来进一步说明本发明,以下实施例为本发明具体的实施方式,但本发明的实施方式并不受下述实施例的限制。
本发明的原料均来源于市购。
实施例1:
原料配比:
百药煎12.5份,薄荷10份,微晶纤维素20.5份,蔗糖粉35份,甘露糖醇27.6份,羧甲基淀粉钠4份,淀粉0.8份,三氯蔗糖0.2份,薄荷香精0.2份,茉莉花香精0.05份,硬脂酸镁0.5份,薄荷脑0.1份。
其制备工艺包括如下步骤:
a)取薄荷,洗净,50℃以下低温干燥,粉碎成40-60目粉末,用超临界二氧化碳萃取,得薄荷油,备用;取百药煎,除去杂质,备用。
b)取超临界二氧化碳萃取后的薄荷,加入百药煎,加水提取两次,第一次加8倍量水,煎煮30分钟,第二次加6倍量水,煎煮30分钟,滤过,合并滤液,在70℃下减压浓缩到相对密度为1.06的清膏,采用喷雾干燥制备得到混合提取物,备用;
c)取薄荷脑,粉碎后过80-100目筛,备用;
d)取三氯蔗糖、蔗糖粉、微晶纤维素、甘露糖醇、羧甲基淀粉钠及b)中混合提取物,混合均匀,得到混合粉,备用;
e)取淀粉,加水制成淀粉浆,均匀倒入d)中的混合粉中,充分混匀,制成软材,后用摇摆制粒机制备得到颗粒,备用;
f)取步骤e)得到颗粒,加入硬脂酸镁,薄荷香精、茉莉花香精,以及c)中的薄荷脑,混合均匀,再均匀喷入a)中的薄荷油,得到颗粒混合物,备用;
g)取f)中的颗粒混合物,用压片机制备得到含片,即得。
实施例2:
原料药配比:
百药煎10份,薄荷20份,微晶纤维素39份,蔗糖粉20份,甘露糖醇25份,羧甲基淀粉钠3份,淀粉1份,三氯蔗糖0.19份,薄荷香精0.25份,茉莉花香精0.1份,硬脂酸镁0.8份,薄荷脑0.08份。
其制备工艺包括如下步骤:
a)取薄荷,洗净,50℃以下低温干燥,粉碎成40-60目粉末,用超临界二氧化碳萃取,得薄荷油,备用;取百药煎,除去杂质,备用。
b)取超临界二氧化碳萃取后的薄荷,加入百药煎,加水提取两次,第一次加7倍量水,煎煮25分钟,第二次加7倍量水,煎煮25分钟,滤过,合并滤液,在60℃下减压浓缩到相对密度为1.08的清膏,采用喷雾干燥制备得到混合提取物,备用;
c)取薄荷脑,粉碎后过80-100目筛,备用;
d)取三氯蔗糖、蔗糖粉、微晶纤维素、甘露糖醇、羧甲基淀粉钠及b)中混合提取物,混合均匀,得到混合粉,备用;
e)取淀粉,加水制成淀粉浆,均匀倒入d)中的混合粉中,充分混匀,制成软材,后用摇摆制粒机制备得到颗粒,备用;
f)取步骤e)得到颗粒,加入硬脂酸镁,薄荷香精、茉莉花香精,以及c)中的薄荷脑,混合均匀,再均匀喷入a)中的薄荷油,得到颗粒混合物,备用;
g)取f)中的颗粒混合物,用压片机制备得到含片,即得。
实施例3:
原料药配比:
百药煎17份,薄荷5份,微晶纤维素24份,蔗糖粉40份,甘露糖醇15份,羧甲基淀粉钠5份,淀粉0.9份,三氯蔗糖0.22份,薄荷香精0.3份,茉莉花香精0.08份,硬脂酸镁1份,薄荷脑0.1份。
其制备工艺包括如下步骤:
a)取薄荷,洗净,50℃以下低温干燥,粉碎成40-60目粉末,用超临界二氧化碳萃取,得薄荷油,备用;取百药煎,除去杂质,备用。
b)取超临界二氧化碳萃取后的薄荷,加入百药煎,加水提取两次,第一次加8倍量水,煎煮30分钟,第二次加7倍量水,煎煮20分钟,滤过,合并滤液,在80℃下减压浓缩到相对密度为1.10的清膏,采用喷雾干燥制备得到混合提取物,备用;
c)取薄荷脑,粉碎后过80-100目筛,备用;
d)取三氯蔗糖、蔗糖粉、微晶纤维素、甘露糖醇、羧甲基淀粉钠及b)中混合提取物,混合均匀,得到混合粉,备用;
e)取淀粉,加水制成淀粉浆,均匀倒入d)中的混合粉中,充分混匀,制成软材,后用摇摆制粒机制备得到颗粒,备用;
f)取步骤e)得到颗粒,加入硬脂酸镁,薄荷香精、茉莉花香精,以及c)中的薄荷脑,混合均匀,再均匀喷入a)中的薄荷油,得到颗粒混合物,备用;
g)取f)中的颗粒混合物,用压片机制备得到含片,即得。
对比例1:
原料药配比:
除蔗糖粉、三氯蔗糖、甘露糖醇、薄荷香精、茉莉花香精、薄荷脑用等量的麦芽糊精替代外,其余与实施例1一致。
百药煎12.5份,薄荷10份,微晶纤维素20.5份,羧甲基淀粉钠4份,淀粉0.8份,硬脂酸镁0.5份,麦芽糊精63份。
其制备工艺包括如下步骤:
a)取薄荷,洗净,50℃以下低温干燥,粉碎成40-60目粉末,用超临界二氧化碳萃取,得薄荷油,备用;取百药煎,除去杂质,备用。
b)取超临界二氧化碳萃取后的薄荷,加入百药煎,加水提取两次,第一次加8倍量水,煎煮30分钟,第二次加6倍量水,煎煮30分钟,滤过,合并滤液,在70℃下减压浓缩到相对密度为1.06的清膏,采用喷雾干燥制备得到混合提取物,备用;
c)取微晶纤维素、羧甲基淀粉钠、麦芽糊精及b)中混合提取物,混合均匀,得到混合粉,备用;
d)取淀粉,加水制成淀粉浆,均匀倒入c)中的混合粉中,充分混匀,制成软材,后用摇摆制粒机制备得到颗粒,备用;
e)取步骤d)得到颗粒,加入硬脂酸镁,混合均匀,再均匀喷入a)中的薄荷油,得到颗粒混合物,备用;
f)取e)中的颗粒混合物,用压片机制备得到含片,即得。
对比例2:
原料药配比:除蔗糖粉、甘露糖醇、三氯蔗糖、薄荷香精、茉莉花香精、薄荷脑用等量的麦芽糊精替代外,薄荷不提取挥发油,其余与实施例1一致。
百药煎12.5份,薄荷10份,微晶纤维素20.5份,羧甲基淀粉钠4份,淀粉0.8份,硬脂酸镁0.5份,麦芽糊精63份。
其制备工艺包括如下步骤:
a)取薄荷,洗净,50℃以下低温干燥,粉碎成40-60目粉末,备用;取百药煎,除去杂质,备用。
b)取薄荷、百药煎,加水提取两次,第一次加8倍量水,煎煮30分钟,第二次加6倍量水,煎煮30分钟,滤过,合并滤液,在70℃下减压浓缩到相对密度为1.06的清膏,采用喷雾干燥制备得到混合提取物,备用;
c)取微晶纤维素、羧甲基淀粉钠、麦芽糊精及b)中混合提取物,混合均匀,得到混合粉,备用;
d)取淀粉,加水制成淀粉浆,均匀倒入c)中的混合粉中,充分混匀,制成软材,后用摇摆制粒机制备得到颗粒,备用;
e)取步骤d)得到颗粒,加入硬脂酸镁,混合均匀,得到颗粒混合物,备用;
f)取e)中的颗粒混合物,用压片机制备得到含片,即得。
征集年龄为18-60岁的50名志愿者,分别对实施例1-3、对比例1-2所制备的缓解口腔及咽喉不适的含片进行感官鉴评,包括对其口感(酸甜度)、风味、清凉度、咽喉舒缓作用、长期服用意愿度等进行评分,每项10分,统计并计算均值;实验结果如下:
由实施例1与对比例1-2相比,对比例1中不添加矫味原料(蔗糖粉、三氯蔗糖、薄荷香精及薄荷脑),直接用麦芽糊精代替原有矫味原料,制备得到的含片虽然有一定的清凉度,对咽喉有较好舒缓作用,但人们长期服用意愿度较低,感官评分较低;对比例2中不添加矫味原料(蔗糖粉、三氯蔗糖、薄荷香精及薄荷脑),直接用麦芽糊精代替原有矫味原料,同时薄荷取消提取挥发油,制备得到的含片虽然对咽喉有较好舒缓作用,但风味滋味较差,感官评分最低;而实施例所制得的含片,具有较好的酸甜度,风味较佳,清凉度强,也有较强的咽喉舒缓作用,人们对长期服用以缓解口腔、咽喉等病症意愿度较高,感官评分较高。
本发明以薄荷与百药煎配伍使用,增强疗效,配以其他辅料,实现酸甜可口,清凉冰爽,可有效缓解咽喉不适,风味独特,具有较好的净化口腔、舒缓咽喉功效,是一种清咽利喉,功效与口感兼具的产品,能实现长期服用以舒缓口腔、咽喉等慢性病症的目的。
Claims (6)
1.一种缓解口腔及咽喉不适的含片,其特征在于,由下述重量份的原料制成:百药煎10-20份,薄荷5-20份,微晶纤维素10-40份,甜味剂30-95份,羧甲基淀粉钠2-8份,淀粉0.5-1.5份,清凉添加剂0.2-0.6,硬脂酸镁0.1-1.0份。
2.根据权利要求1所述的一种缓解口腔及咽喉不适的含片,其特征在于,由下述重量份的原料制成:百药煎12.5份,薄荷10份,微晶纤维素20.5份,甜味剂63份,羧甲基淀粉钠4份,淀粉0.8份,清凉添加剂0.25份,硬脂酸镁0.5份,薄荷脑0.1份。
3.根据权利要求1或2所述的一种缓解口腔及咽喉不适的含片,其特征在于,所述清凉添加剂为薄荷香精、茉莉花香精和薄荷脑按0.1-0.3:0.05-0.15:0.05-0.15的复配物,优选为薄荷香精、茉莉花香精和薄荷脑按0.2:0.05:0.1的复配物。
4.根据权利要求1或2所述的一种缓解口腔及咽喉不适的含片,其特征在于,所述甜味剂为蔗糖粉、三氯蔗糖和甘露糖醇按25-45:9.8-48:0.19-0.22的复配物,优选为蔗糖粉、三氯蔗糖和甘露糖醇按35:27.6:0.2的复配物。
5.根据权利要求1-4任一项所述的一种缓解口腔及咽喉不适的含片的制备方法,其特征在于,包括如下步骤:
a)取薄荷,洗净,50℃以下低温干燥,粉碎成40-60目细粉,用超临界二氧化碳萃取,得薄荷油,备用;取百药煎,除去杂质,备用;
b)取超临界二氧化碳萃取后的薄荷,加入百药煎,加水提取两次,第一次加7-8倍量水,煎煮20-30分钟,第二次加6-7倍量水,煎煮20-30分钟,滤过,合并滤液,在60-80℃下减压浓缩到相对密度为1.06-1.10的清膏,采用喷雾干燥制备得到混合提取物,备用;
c)取薄荷脑,粉碎后过80-100目筛,备用;
d)取三氯蔗糖、蔗糖粉、微晶纤维素、甘露糖醇、羧甲基淀粉钠及b)中混合提取物,混合均匀,得到混合粉,备用;
e)取淀粉,加水制成淀粉浆,均匀倒入d)中的混合粉中,充分混匀,制成软材,后用摇摆制粒机制备得到颗粒,备用;
f)取步骤e)得到颗粒,加入硬脂酸镁,薄荷香精、茉莉花香精,以及c)中的薄荷脑粉末,混合均匀,再均匀喷入a)中的薄荷油,得到颗粒混合物,备用;
g)取f)中的颗粒混合物,用压片机制备得到含片,即得。
6.根据权利要求5所述的一种缓解口腔及咽喉不适的含片的制备方法,其特征在于,步骤a)中,所述超临界二氧化碳萃取条件为:萃取釜压力20~25MPa,分离Ⅰ压力5~10 MPa,分离Ⅱ压力4~8 MPa,萃取温度为35~45℃,分离Ⅰ温度为45~55℃,分离Ⅱ温度为30~35℃,二氧化碳流量为20-30L/h,萃取时间为1.5-3小时。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811568246.3A CN109481497B (zh) | 2018-12-21 | 2018-12-21 | 一种缓解口腔及咽喉不适的含片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811568246.3A CN109481497B (zh) | 2018-12-21 | 2018-12-21 | 一种缓解口腔及咽喉不适的含片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109481497A true CN109481497A (zh) | 2019-03-19 |
CN109481497B CN109481497B (zh) | 2021-07-20 |
Family
ID=65711198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811568246.3A Active CN109481497B (zh) | 2018-12-21 | 2018-12-21 | 一种缓解口腔及咽喉不适的含片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109481497B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110403891A (zh) * | 2019-07-26 | 2019-11-05 | 成都中医药大学 | 一种具有口腔保健作用的中草药牙膏 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1895535A (zh) * | 2005-07-14 | 2007-01-17 | 黄开智 | 用于治疗咽喉疾病的中药制剂及其生产方法 |
CN101455778A (zh) * | 2008-12-29 | 2009-06-17 | 北京同仁堂股份有限公司 | 一种清热利咽的中药制剂及其制备方法 |
CN104338011A (zh) * | 2013-08-01 | 2015-02-11 | 济南伟传信息技术有限公司 | 一种治疗慢性咽炎的中药 |
CN105079798A (zh) * | 2015-09-15 | 2015-11-25 | 孟庆蕾 | 一种治疗小儿痰热阻肺证的药物组合物及其制备方法 |
CN105497739A (zh) * | 2014-09-24 | 2016-04-20 | 陈玉梅 | 一种治疗咽炎的中药方 |
-
2018
- 2018-12-21 CN CN201811568246.3A patent/CN109481497B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1895535A (zh) * | 2005-07-14 | 2007-01-17 | 黄开智 | 用于治疗咽喉疾病的中药制剂及其生产方法 |
CN101455778A (zh) * | 2008-12-29 | 2009-06-17 | 北京同仁堂股份有限公司 | 一种清热利咽的中药制剂及其制备方法 |
CN104338011A (zh) * | 2013-08-01 | 2015-02-11 | 济南伟传信息技术有限公司 | 一种治疗慢性咽炎的中药 |
CN105497739A (zh) * | 2014-09-24 | 2016-04-20 | 陈玉梅 | 一种治疗咽炎的中药方 |
CN105079798A (zh) * | 2015-09-15 | 2015-11-25 | 孟庆蕾 | 一种治疗小儿痰热阻肺证的药物组合物及其制备方法 |
Non-Patent Citations (4)
Title |
---|
徐兴家: "百药煎是什么药,是否可用五倍子代替使用?", 《中医药学刊》 * |
谢志刚: "清咽丸含化为主治疗慢性咽炎疗效观察 ", 《陕西中医》 * |
赵春凤,等: "巧用五倍子", 《中国中医药现代远程教育》 * |
韦博: "咽喉肿痛中医疗法", 《农村新技术》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110403891A (zh) * | 2019-07-26 | 2019-11-05 | 成都中医药大学 | 一种具有口腔保健作用的中草药牙膏 |
Also Published As
Publication number | Publication date |
---|---|
CN109481497B (zh) | 2021-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105148017B (zh) | 一种具有润肺止咳功能的饮料 | |
CN102177998B (zh) | 一种清咽利喉保健茶 | |
CN103564587B (zh) | 一种天然黄腐酸复合保健饮料及其制备方法 | |
CN100393226C (zh) | 三参解烟排毒保健茶 | |
CN102198065A (zh) | 一种口腔喷雾剂及其制备方法 | |
CN102258569B (zh) | 一种治疗口腔炎、咽喉炎的中药组合物及其制备方法 | |
CN104041644A (zh) | 润肠茶及其制备方法 | |
CN103356891A (zh) | 一种无糖清咽含片及其制备方法 | |
CN104000195B (zh) | 清肺排毒口服液及其生产方法 | |
CN104547515A (zh) | 一种橘红梨膏及其制备方法 | |
CN104799616A (zh) | 一种用于保健安眠的中药床垫 | |
CN110313597A (zh) | 一种速溶免冲润喉颗粒及其制备方法 | |
CN101536717A (zh) | 养生普洱茶 | |
CN105105315B (zh) | 一种清咽利嗓型烟草粉末喷剂及其制备方法 | |
CN109481497A (zh) | 一种缓解口腔及咽喉不适的含片及其制备方法 | |
CN109464540A (zh) | 一种缓解口腔及咽喉不适的喷雾剂及其制备方法 | |
CN105832619A (zh) | 杀菌除臭足浴盐及制备方法 | |
CN103623120B (zh) | 一种清咽利喉含片及其制备方法 | |
CN104383232B (zh) | 清热解毒苦丁茶含片及其生产方法 | |
CN108185054A (zh) | 一种肺宝茶及其制备方法 | |
CN1215801C (zh) | 一种防病保健饮料及其制法 | |
CN103584226B (zh) | 清热降火的饮料及其制备方法 | |
CN101543590A (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
CN103222519A (zh) | 一种凉茶 | |
CN109045193A (zh) | 一种咽喉炎喷雾剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231122 Address after: No. 21 and 22, Qifeng Industrial Zone, Ganjiao Community, Lishui Town, Nanhai District, Foshan City, Guangdong Province, 528200 Patentee after: Guangdong Qifeng Health Industry Co.,Ltd. Address before: 528244 Qifeng Industrial Development Zone, Lishui Town, Nanhai District, Foshan City, Guangdong Province Patentee before: GUANGDONG YIFANG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |